Fig. 7.
(a) Comparison of dose distribution on a transverse slice for prostate case between AP_RTOG plans (left) and AP_PlanIQ plans (right), (b) DVH comparison for prostate case between AP_RTOG plans (dotted lines) and AP_PlanIQ plans (solid lines) and (c) comparison of dose statistics for prostate case between AP_RTOG plans and AP_PlanIQ plans.